SLC19A1 and renal cell adenocarcinoma: We utilized data from a recent genome-wide association study (GWAS) of renal cancer [22] with over 3700 Caucasian cases and 8400 controls to look specifically at the association between the two significant SLC19A1 SNPs identified in our study and RCC risk in the GWAS population.